Ahold Delhaize
2.2.2021 07:46:24 CET | Globenewswire | Press release
Zaandam, the Netherlands, February 2, 2021 – Ahold Delhaize today announces the nomination of Jan Zijderveld for appointment to Ahold Delhaize’s Supervisory Board, effective April 14, 2021.
Jan Zijderveld is a Dutch national, who spent almost 30 years at Unilever holding several senior management positions in 7 different countries, ending up as CEO & President of Unilever Europe and member of Unilever executive team. Jan served as Chief Executive Officer of Avon as of 2018 and left the company in 2020 after a successful turnaround of its business ultimately resulting in an acquisition of the company by The Natura & Co. Currently Jan holds several advisory functions.
"We are pleased to propose Jan for appointment to the Supervisory Board. He will bring extensive international experience, consumer insights in a broad range of products and valuable knowledge of the global retail space. With his arrival, we found the skills and competencies that will be important to the Supervisory Board as Ahold Delhaize is executing its Leading Together strategy and the Supervisory Board continues to evolve" said Chair of the Supervisory Board, Peter Agnefjäll.
The Supervisory Board will propose the appointment to the Annual General Meeting on April 14, 2021.
Cautionary notice
This communication includes forward-looking statements. All statements other than statements of historical facts may be forward-looking statements. Words and expressions such as propose, will, bring, be, strategy, continues, evolve or other similar words or expressions are typically used to identify forward-looking statements.
Forward-looking statements are subject to risks, uncertainties and other factors that are difficult to predict and that may cause actual results of Koninklijke Ahold Delhaize N.V. (the "Company") to differ materially from future results expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risk factors set forth in the Company’s public filings and other disclosures. Forward-looking statements reflect the current views of the Company’s management and assumptions based on information currently available to the Company’s management. Forward-looking statements speak only as of the date they are made and the Company does not assume any obligation to update such statements, except as required by law.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S25.10.2026 12:00:00 CET | Press release
Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
Genmab A/S24.10.2026 13:00:00 CEST | Press release
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
ASYAD24.10.2026 12:47:36 CEST | Press release
Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks
King Faisal Specialist Hospital & Research Centre24.10.2026 11:00:00 CEST | Press release
KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
Orion Oyj24.10.2026 08:35:00 CEST | Press release
Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
